The Role of Genetics in Sporadic GEP-NETs: A Comprehensive Review of the Literature

[1]Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;1: 238-239.14000847WilliamsEDSandlerM.The classification of carcinoid tumoursLancet1963123823910.1016/S0140-6736(63)90951-6Search in Google Scholar

[2]Yao JC, Hassan M, Phan A et al. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825cases in the United States. J Clin Oncol. 2008; 26: 3063-30721856589410.1200/JCO.2007.15.4377YaoJCHassanMPhanAOne hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825cases in the United StatesJ Clin Oncol.2008263063307218565894Search in Google Scholar

[3]https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdfhttps://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdfSearch in Google Scholar

[4]Niklas Gebauer, Christian Schmidt-Werthern, Veronica Bernard et al.Genomic landscape of pancreatic neuroendocrine tumors. World J Gastroenterol 2014 December 14; 20(46): 17498-175062551666410.3748/wjg.v20.i46.17498NiklasGebauerChristianSchmidt-WerthernVeronicaBernardGenomic landscape of pancreatic neuroendocrine tumorsWorld J Gastroenterol2014December 1420461749817506426561125516664Search in Google Scholar

[5]Joakim Crona, Britt Skogseid. Genetics of neuroendocrine tumors. European Journal of Endocrinology(2016) 174, R275–R290JoakimCronaBrittSkogseidGenetics of neuroendocrine tumorsEuropean Journal of Endocrinology2016174R275R29010.1530/EJE-15-097227165966Search in Google Scholar

[6]Ken-Shwo Dai, Wei Wei, Choong-Chin Liew. Molecular Cloning and Characterization of a Novel Human Gene Containing Ankyrin Repeat and Double BTB/POZ Domain. Biochemical and Biophysical Research Communications 273, 991– 996 (2000)10.1006/bbrc.2000.305310891360Ken-ShwoDaiWeiWeiChoong-ChinLiewMolecular Cloning and Characterization of a Novel Human Gene Containing Ankyrin Repeat and Double BTB/POZ DomainBiochemical and Biophysical Research Communications273991996200010891360Open DOISearch in Google Scholar

[7]Pérez-Magán E, Rodríguez de Lope A, Ribalta T et al. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. Neuro Oncol 2010; 12: 1278-12902068572010.1093/neuonc/noq081Pérez-MagánERodríguez de LopeARibaltaTDifferential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomasNeuro Oncol20101212781290301893720685720Search in Google Scholar

[8]Jen J1, Lin LL2, Chen HT3 et al. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer. Oncogene,2016 May 5;35(18):2357-692627930410.1038/onc.2015.296JenJ1LinLL2ChenHT3Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancerOncogene2016May 53518235769486547526279304Search in Google Scholar

[9]Aragane H, Sakakura C, Nakanishi M et al. Chromosomal aberrations in colorectal cancersand liver metastases analyzed by comparative genomic hybridization. Int J Cancer 2001; 94: 623-6291174545510.1002/ijc.1522AraganeHSakakuraCNakanishiMChromosomal aberrations in colorectal cancersand liver metastases analyzed by comparative genomic hybridizationInt J Cancer20019462362911745455Search in Google Scholar

[10]Schmidt H, Taubert H, Würl P et al. Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. Genes Chromosomes Cancer 2002; 34: 69-7710.1002/gcc.1003611921284SchmidtHTaubertHWürlPGains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcomeGenes Chromosomes Cancer200234697711921284Open DOISearch in Google Scholar

[11]Hale JS, Li M, Sinyuk M, Jahnen-Dechent W et al. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesisand growth. PLoS One 2012; 7: e4003310.1371/journal.pone.0040033HaleJSLiMSinyukMJahnen-DechentWContext dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesisand growthPLoS One20127e40033339373422808089Open DOISearch in Google Scholar

[12]May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999, 18 (53): 7621–361061870210.1038/sj.onc.1203285MayPMayE.Twenty years of p53 research: structural and functional aspects of the p53 proteinOncogene1999185376213610618702Search in Google Scholar

[13]Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137: 413-4311941054010.1016/j.cell.2009.04.037VousdenKHPrivesC.Blinded by the Light: The Growing Complexity of p53Cell200913741343119410540Search in Google Scholar

[14]Marinoni I, Kurrer AS, Vassella E et al. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 2014, 146, 453–460.10.1053/j.gastro.2013.10.02024148618MarinoniIKurrerASVassellaELoss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumorsGastroenterology201414645346024148618Open DOISearch in Google Scholar

[15]Lovejoy CA, Li W, Reisenweber S et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genetics 2012 8.LovejoyCALiWReisenweberSLoss of ATRX genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayPLoS Genetics2012810.1371/journal.pgen.1002772340058122829774Search in Google Scholar

[16]Jonkers YM, Claessen SM, Perren A et al. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocrine-Related Cancer 2007 14 769–779.10.1677/ERC-07-011117914106JonkersYMClaessenSMPerrenADNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patientsEndocrine-Related Cancer20071476977917914106Open DOISearch in Google Scholar

[17]Guertin DA, Sabatini DM . Defining the role of mTOR in cancer. Cancer Cell 2009, 12 (1): 9–22.GuertinDASabatiniDM.Defining the role of mTOR in cancerCancer Cell200912192210.1016/j.ccr.2007.05.00817613433Search in Google Scholar

[18]Verger A, Duterque-Coquillaud M. When Ets transcription factors meet their partners. Bioessays. 2002 Apr;24(4):362-70.10.1002/bies.1006811948622VergerADuterque-CoquillaudM.When Ets transcription factors meet their partnersBioessays.2002Apr2443627011948622Open DOISearch in Google Scholar

[19]Li YX, Jin HG, Yan CG et al. Molecular cloning, sequence identification, and gene expression analysis of bovine ADCY2 gene. Mol Biol Rep. 2014 Jun;41(6):3561-810.1007/s11033-014-3167-924797538LiYXJinHGYanCGMolecular cloning, sequence identification, and gene expression analysis of bovine ADCY2 geneMol Biol Rep.2014Jun4163561824797538Open DOISearch in Google Scholar

[20]Sacchetti P, Carpentier R, Ségard P et al. Multiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR1. Nucleic Acids Res. 2006;34(19):5515-2710.1093/nar/gkl71217020917SacchettiPCarpentierRSégardPMultiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR1Nucleic Acids Res.20063419551527163649017020917Open DOISearch in Google Scholar

[21]Lee D, Sohn H, Kalpana GV et al. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 399 (6735): 487–91036596310.1038/20966LeeDSohnHKalpanaGVInteraction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNANature3996735487910365963Search in Google Scholar

[22]Le Tourneau C, Paoletti X, Servant N, et al. Randomised proof-of-conceptphase II trial comparing targeted therapy based on tumour molecularprofiling vs conventional therapy in patients with refractory cancer: results ofthe feasibility part of the SHIVA trial. Br J Cancer. 2014; 111: 17-24.10.1038/bjc.2014.211Le TourneauCPaolettiXServantNRandomised proof-of-conceptphase II trial comparing targeted therapy based on tumour molecularprofiling vs conventional therapy in patients with refractory cancer: results ofthe feasibility part of the SHIVA trialBr J Cancer.20141111724Open DOISearch in Google Scholar

[23]Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 2007 26 (57): 7825–32.10.1038/sj.onc.121059417599048Sanchez-CespedesM.A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndromeOncogene20072657782532Open DOISearch in Google Scholar

[24]Knowles PP, Murray-Rust J, Kjaer S et al. Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem. 2006 Nov 3;281(44):33577-871692868310.1074/jbc.M605604200KnowlesPPMurray-RustJKjaerSStructure and chemical inhibition of the RET tyrosine kinase domainJ Biol Chem.2006Nov 3281443357787Search in Google Scholar

[25]Xiao-Ping Qi,1,* Ju-Ming Ma,1 Zhen-Fang Du et al. RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family. PLoS One. 2011; 6(5): e20353.10.1371/journal.pone.0020353Xiao-PingQi,1,*Ju-MingMa,1Zhen-FangDuRET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma FamilyPLoS One.201165e20353Open DOISearch in Google Scholar

[26]Park C, Ha SY, Kim ST et al. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors. Oncotarget. 2016 Jan 26;7(4):4024-3510.18632/oncotarget.660226684240ParkCHaSYKimSTIdentification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumorsOncotarget.2016Jan 2674402435Open DOISearch in Google Scholar

[27]Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 1991 Sep 20;66(6):1197-206.183306610.1016/0092-8674(91)90042-WLewDJDulicVReedSI.Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeastCell.1991Sep 206661197206Search in Google Scholar